Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies
Authors
Keywords
-
Journal
Journal of Neuroinflammation
Volume 18, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-09-16
DOI
10.1186/s12974-021-02249-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Blood-brain barrier resealing in neuromyelitis optica occurs independently of astrocyte regeneration
- (2021) Anne Winkler et al. JOURNAL OF CLINICAL INVESTIGATION
- Discontinuation of Immunosuppressive Therapy in Patients With Neuromyelitis Optica Spectrum Disorder With Aquaporin-4 Antibodies
- (2021) Su-Hyun Kim et al. Neurology-Neuroimmunology & Neuroinflammation
- What's New in the Treatment of Systemic Lupus Erythematosus
- (2021) Stamatis Nick Liossis et al. Frontiers in Medicine
- Pregnancy in Patients With AQP4-Ab, MOG-Ab, or Double-Negative Neuromyelitis Optica Disorder
- (2021) Nicolas Collongues et al. NEUROLOGY
- The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody
- (2020) Romana Höftberger et al. ACTA NEUROPATHOLOGICA
- Effect of autologous hematopoietic stem cell transplantation on multiple sclerosis and neuromyelitis optica spectrum disorder: a PRISMA-compliant meta-analysis
- (2020) Pengcheng Zhang et al. BONE MARROW TRANSPLANTATION
- Neuromyelitis optica spectrum disorders and pregnancy: therapeutic considerations
- (2020) Yang Mao-Draayer et al. Nature Reviews Neurology
- Pharmacokinetic and pharmacodynamic effects of ravulizumab and eculizumab on complement component 5 in adults with paroxysmal nocturnal haemoglobinuria: results of two phase 3 randomised, multicentre studies
- (2020) Régis Peffault de Latour et al. BRITISH JOURNAL OF HAEMATOLOGY
- Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial
- (2020) Anthony Traboulsee et al. LANCET NEUROLOGY
- Safety and efficacy of tocilizumab versus azathioprine in highly relapsing neuromyelitis optica spectrum disorder (TANGO): an open-label, multicentre, randomised, phase 2 trial
- (2020) Chao Zhang et al. LANCET NEUROLOGY
- Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial
- (2020) Masayuki Tahara et al. LANCET NEUROLOGY
- A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis
- (2020) Edward Fox et al. Multiple Sclerosis Journal
- Efficacy and safety of mycophenolate mofetil therapy in neuromyelitis optica spectrum disorders: a systematic review and meta-analysis
- (2020) Sakdipat Songwisit et al. Scientific Reports
- Intravenous immunoglobulin for acute attacks in neuromyelitis optica spectrum disorders (NMOSD)
- (2020) Xindi Li et al. Multiple Sclerosis and Related Disorders
- Latin American consensus recommendations for management and treatment of neuromyelitis optica spectrum disorders in clinical practice
- (2020) Edgar Carnero Contentti et al. Multiple Sclerosis and Related Disorders
- Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiology
- (2020) Kazuo Fujihara et al. Neurology-Neuroimmunology & Neuroinflammation
- New therapies for neuromyelitis optica spectrum disorder
- (2020) Michael Levy et al. LANCET NEUROLOGY
- Effectiveness of rituximab in neuromyelitis optica: a meta-analysis
- (2019) Fulin Gao et al. BMC Neurology
- Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders
- (2019) Jacqueline Palace et al. BRAIN
- Eculizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder
- (2019) Sean J. Pittock et al. NEW ENGLAND JOURNAL OF MEDICINE
- A pilot safety study of ublituximab, a monoclonal antibody against CD20, in acute relapses of neuromyelitis optica spectrum disorder
- (2019) Maureen A. Mealy et al. MEDICINE
- Does time equal vision in the acute treatment of a cohort of AQP4 and MOG optic neuritis?
- (2019) Hadas Stiebel-Kalish et al. Neurology-Neuroimmunology & Neuroinflammation
- Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
- (2019) Bruce A C Cree et al. LANCET
- Efficacy and tolerability of azathioprine for neuromyelitis optica spectrum disorder: A systematic review and meta-analysis
- (2019) Adrian I. Espiritu et al. Multiple Sclerosis and Related Disorders
- Autologous nonmyeloablative hematopoietic stem cell transplantation for neuromyelitis optica
- (2019) Richard K. Burt et al. NEUROLOGY
- Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder
- (2019) Takashi Yamamura et al. NEW ENGLAND JOURNAL OF MEDICINE
- Affinity-matured ‘aquaporumab’ anti-aquaporin-4 antibody for therapy of seropositive neuromyelitis optica spectrum disorders
- (2019) Tianjiao Duan et al. NEUROPHARMACOLOGY
- A pilot study comparing treatments for severe attacks of neuromyelitis optica spectrum disorders: Intravenous methylprednisolone (IVMP) with add-on plasma exchange (PLEX) versus simultaneous ivmp and PLEX
- (2019) Thanapon Songthammawat et al. Multiple Sclerosis and Related Disorders
- Effectiveness of subcutaneous tocilizumab in neuromyelitis optica spectrum disorders
- (2019) Itay Lotan et al. Multiple Sclerosis and Related Disorders
- Mechanisms underlying lesion development and lesion distribution in CNS autoimmunity
- (2018) Maren Lindner et al. JOURNAL OF NEUROCHEMISTRY
- MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
- (2018) S. Jarius et al. Journal of Neuroinflammation
- CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications
- (2018) Kimihiko Kaneko et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
- (2018) Alan J Thompson et al. LANCET NEUROLOGY
- Treating neuromyelitis optica with azathioprine: 20-year clinical practice
- (2018) Denis Bernardi Bichuetti et al. Multiple Sclerosis Journal
- Recommendations for the use of Rituximab in neuromyelitis optica spectrum disorders
- (2018) J. Ciron et al. REVUE NEUROLOGIQUE
- Treating neuromyelitis optica with azathioprine: 20-year clinical practice
- (2018) Denis Bernardi Bichuetti et al. Multiple Sclerosis Journal
- Neuromyelitis optica spectrum disorders and pregnancy: relapse-preventive measures and personalized treatment strategies
- (2018) Nadja Borisow et al. EPMA Journal
- Complement-dependent bystander injury to neurons in AQP4-IgG seropositive neuromyelitis optica
- (2018) Tianjiao Duan et al. Journal of Neuroinflammation
- Myelin oligodendrocyte glycoprotein antibodies in neurological disease
- (2018) Markus Reindl et al. Nature Reviews Neurology
- Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies
- (2018) Borislav Dejanovic et al. NEURON
- A multicentre randomiSed controlled TRial of IntraVEnous immunoglobulin compared with standard therapy for the treatment of transverse myelitis in adults and children (STRIVE)
- (2017) Michael Absoud et al. HEALTH TECHNOLOGY ASSESSMENT
- Comparison of the efficacy of azathioprine and rituximab in neuromyelitis optica spectrum disorder: a randomized clinical trial
- (2017) Zahra Nikoo et al. JOURNAL OF NEUROLOGY
- Short delay to initiate plasma exchange is the strongest predictor of outcome in severe attacks of NMO spectrum disorders
- (2017) Mickael Bonnan et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response
- (2017) Jan-Patrick Stellmann et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Neuromyelitis optica spectrum disorders and pregnancy: Interactions and management
- (2017) Eslam Shosha et al. Multiple Sclerosis Journal
- High risk of postpartum relapses in neuromyelitis optica spectrum disorder
- (2017) Eric C. Klawiter et al. NEUROLOGY
- Safety and Efficacy of Bortezomib in Patients With Highly Relapsing Neuromyelitis Optica Spectrum Disorder
- (2017) Chao Zhang et al. JAMA Neurology
- Neuromyelitis optica spectrum disorders and pregnancy: Interactions and management
- (2017) Eslam Shosha et al. Multiple Sclerosis Journal
- High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine
- (2017) Lucy A. McNamara et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Neurodegeneration in multiple sclerosis and neuromyelitis optica
- (2016) Izumi Kawachi et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Effectiveness of mycophenolate mofetil as first-line therapy in AQP4-IgG, MOG-IgG, and seronegative neuromyelitis optica spectrum disorders
- (2016) Alexis Montcuquet et al. Multiple Sclerosis Journal
- Efficacy and Safety of Rituximab Therapy in Neuromyelitis Optica Spectrum Disorders
- (2016) Valentina Damato et al. JAMA Neurology
- Effectiveness of mycophenolate mofetil as first-line therapy in AQP4-IgG, MOG-IgG, and seronegative neuromyelitis optica spectrum disorders
- (2016) Alexis Montcuquet et al. Multiple Sclerosis Journal
- Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses
- (2015) Ingo Kleiter et al. ANNALS OF NEUROLOGY
- Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes
- (2015) Maciej Juryńczyk et al. JOURNAL OF NEUROLOGY
- Comparative analysis of treatment outcomes in patients with neuromyelitis optica spectrum disorder using multifaceted endpoints
- (2015) In Hye Jeong et al. Multiple Sclerosis Journal
- Treatment of acute relapses in neuromyelitis optica: Steroids alone versus steroids plus plasma exchange
- (2015) Hesham Abboud et al. Multiple Sclerosis Journal
- International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
- (2015) Dean M. Wingerchuk et al. NEUROLOGY
- Clinical features of neuromyelitis optica in children
- (2015) Tanuja Chitnis et al. NEUROLOGY
- Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder
- (2015) Marius Ringelstein et al. JAMA Neurology
- Comparative analysis of treatment outcomes in patients with neuromyelitis optica spectrum disorder using multifaceted endpoints
- (2015) In Hye Jeong et al. Multiple Sclerosis Journal
- Treatment of acute relapses in neuromyelitis optica: Steroids alone versus steroids plus plasma exchange
- (2015) Hesham Abboud et al. Multiple Sclerosis Journal
- Neuromyelitis optica IgG stimulates an immunological response in rat astrocyte cultures
- (2014) Charles L. Howe et al. GLIA
- Eosinophil Granule Proteins: Form and Function
- (2014) K. Ravi Acharya et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Functional Consequences of Neuromyelitis Optica-IgG Astrocyte Interactions on Blood-Brain Barrier Permeability and Granulocyte Recruitment
- (2014) T. Vincent et al. JOURNAL OF IMMUNOLOGY
- Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospective observational study from the UK
- (2014) Liene Elsone et al. Multiple Sclerosis Journal
- Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders
- (2014) D. K. Sato et al. NEUROLOGY
- Efficacy of the anti-IL-6 receptor antibody tocilizumab in neuromyelitis optica: A pilot study
- (2014) M. Araki et al. NEUROLOGY
- Mycophenolate Mofetil in the Treatment of Neuromyelitis Optica Spectrum Disorder
- (2014) So-Young Huh et al. JAMA Neurology
- Comparison of Relapse and Treatment Failure Rates Among Patients With Neuromyelitis Optica
- (2014) Maureen A. Mealy et al. JAMA Neurology
- Neuromyelitis optica pathology in rats following intraperitoneal injection of NMO-IgG and intracerebral needle injury
- (2014) Nithi Asavapanumas et al. Acta Neuropathologica Communications
- The Pathology of an Autoimmune Astrocytopathy: Lessons Learned from Neuromyelitis Optica
- (2013) Claudia F. Lucchinetti et al. BRAIN PATHOLOGY
- Clinical Efficacy of Plasmapheresis in Patients with Neuromyelitis Optica Spectrum Disorder and Effects on Circulating Anti-Aquaporin-4 Antibody Levels
- (2013) Su-Hyun Kim et al. Journal of Clinical Neurology
- MHC class II–dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies
- (2013) Nicolas Molnarfi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Role of intravenous immunoglobulin in the treatment of acute relapses of neuromyelitis optica: experience in 10 patients
- (2013) Liene Elsone et al. Multiple Sclerosis Journal
- Plasmablasts as Migratory IgG-Producing Cells in the Pathogenesis of Neuromyelitis Optica
- (2013) Norio Chihara et al. PLoS One
- Aquaporin 4 Expression and Tissue Susceptibility to Neuromyelitis Optica
- (2013) Marcelo Matiello et al. JAMA Neurology
- Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss
- (2012) Julien Ratelade et al. ACTA NEUROPATHOLOGICA
- Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognizeClostridiumABC transporter
- (2012) Michel Varrin-Doyer et al. ANNALS OF NEUROLOGY
- Lack of Response to Pulse Cyclophosphamide in Neuromyelitis Optica
- (2012) Denis B. Bichuetti et al. ARCHIVES OF NEUROLOGY
- Complement-dependent Cytotoxicity in Neuromyelitis Optica Requires Aquaporin-4 Protein Assembly in Orthogonal Arrays
- (2012) Puay-Wah Phuan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Ex Vivo Production of IL-6 and IL-21 by CD4+ T Cells is Directly Associated with Neurological Disability in Neuromyelitis Optica Patients
- (2012) Ulisses C. Linhares et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients
- (2012) Sven Jarius et al. Journal of Neuroinflammation
- Testing for antibodies to human aquaporin-4 by ELISA: Sensitivity, specificity, and direct comparison with immunohistochemistry
- (2012) S. Jarius et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Aquaporin 4 and neuromyelitis optica
- (2012) Marios C Papadopoulos et al. LANCET NEUROLOGY
- Impaired regulatory function and enhanced intrathecal activation of B cells in neuromyelitis optica: distinct from multiple sclerosis
- (2012) Chao Quan et al. Multiple Sclerosis Journal
- Protective effect of an elastase inhibitor in a neuromyelitis optica-like disease driven by a peptide of myelin oligodendroglial glycoprotein
- (2012) Katja Herges et al. Multiple Sclerosis Journal
- Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain
- (2011) Samira Saadoun et al. ANNALS OF NEUROLOGY
- Pathology of Demyelinating Diseases
- (2011) Bogdan F.Gh. Popescu et al. Annual Review of Pathology-Mechanisms of Disease
- Repeated Treatment With Rituximab Based on the Assessment of Peripheral Circulating Memory B Cells in Patients With Relapsing Neuromyelitis Optica Over 2 Years
- (2011) Su-Hyun Kim ARCHIVES OF NEUROLOGY
- Binding Affinity and Specificity of Neuromyelitis Optica Autoantibodies to Aquaporin-4 M1/M23 Isoforms and Orthogonal Arrays
- (2011) Jonathan M. Crane et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders
- (2011) Simone Mader et al. Journal of Neuroinflammation
- Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: Results from 211 lumbar punctures
- (2011) S. Jarius et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Quantitative measurement of anti-aquaporin-4 antibodies by enzyme-linked immunosorbent assay using purified recombinant human aquaporin-4
- (2011) Woojun Kim et al. Multiple Sclerosis Journal
- Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab
- (2011) H. L. Pellkofer et al. NEUROLOGY
- Intravenous Neuromyelitis Optica Autoantibody in Mice Targets Aquaporin-4 in Peripheral Organs and Area Postrema
- (2011) Julien Ratelade et al. PLoS One
- Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes
- (2011) S. R. Hinson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica
- (2011) Norio Chihara et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Follicular Helper T Cell Differentiation Requires Continuous Antigen Presentation that Is Independent of Unique B Cell Signaling
- (2010) Elissa K. Deenick et al. IMMUNITY
- Complement Component C1q Mediates Mitochondria-Driven Oxidative Stress in Neonatal Hypoxic-Ischemic Brain Injury
- (2010) V. S. Ten et al. JOURNAL OF NEUROSCIENCE
- Preferential increase of B-cell activating factor in the cerebrospinal fluid of neuromyelitis optica in a white population
- (2010) Adi Vaknin-Dembinsky et al. Multiple Sclerosis Journal
- Different HLA class II (DRB1 and DQB1) alleles determine either susceptibility or resistance to NMO and multiple sclerosis among the French Afro-Caribbean population
- (2010) R Deschamps et al. Multiple Sclerosis Journal
- Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo
- (2009) Monika Bradl et al. ANNALS OF NEUROLOGY
- Intrathecal pathogenic antiâaquaporin-4 antibodies in early neuromyelitis optica
- (2009) Jeffrey L. Bennett et al. ANNALS OF NEUROLOGY
- Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder
- (2009) M Bonnan et al. Multiple Sclerosis Journal
- HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis
- (2009) Doralina Guimaraães Brum et al. Multiple Sclerosis Journal
- NMO-IgG DETECTED IN CSF IN SERONEGATIVE NEUROMYELITIS OPTICA
- (2009) E. C. Klawiter et al. NEUROLOGY
- Antibody to aquaporin-4 in the long-term course of neuromyelitis optica
- (2008) S. Jarius et al. BRAIN
- Aquaporin-4–binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2
- (2008) Shannon R. Hinson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Differential diagnosis of suspected multiple sclerosis: a consensus approach
- (2008) DH Miller et al. Multiple Sclerosis Journal
- IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells
- (2008) T. Korn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now